AlzeCure Pharma (ST:ALZCUR) — Market Cap & Net Worth
Market Cap & Net Worth: AlzeCure Pharma (ALZCUR)
AlzeCure Pharma (ST:ALZCUR) has a market capitalization of $95.72 Million (Skr889.44 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #19441 globally and #342 in its home market, demonstrating a -7.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AlzeCure Pharma's stock price Skr7.74 by its total outstanding shares 114914455 (114.91 Million). Also see AlzeCure Pharma balance sheet assets for a full breakdown of the balance sheet.
AlzeCure Pharma Market Cap History: 2018 to 2026
AlzeCure Pharma's market capitalization history from 2018 to 2026. Data shows change from $102.38 Million to $95.72 Million (-4.40% CAGR). Also see AlzeCure Pharma cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
AlzeCure Pharma is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.23 Billion | 0.63% | #35 of 281 |
Weight: AlzeCure Pharma's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AlzeCure Pharma Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AlzeCure Pharma's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest AlzeCure Pharma stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ALZCUR by Market Capitalization
Companies near AlzeCure Pharma in the global market cap rankings as of September 19, 2026. Review tangible net worth ratio of AlzeCure Pharma to assess the quality of the company's equity after excluding intangible assets.
Key companies related to AlzeCure Pharma by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $128.84 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #340 globally with a market cap of $79.38 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $60.28 Billion USD ( AU$85.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $128.84 Billion | $508.34 |
| #340 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.38 Billion | $784.85 |
| #459 | CSL Ltd | AU:CSL | $60.28 Billion | AU$175.59 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $154.04 |
AlzeCure Pharma Historical Marketcap From 2018 to 2026
Between 2018 and today, AlzeCure Pharma's market cap moved from $102.38 Million to $ 95.72 Million, with a yearly change of -4.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr95.72 Million | +287.00% |
| 2025 | Skr24.73 Million | +73.91% |
| 2024 | Skr14.22 Million | -63.02% |
| 2023 | Skr38.46 Million | -24.88% |
| 2022 | Skr51.20 Million | -30.42% |
| 2021 | Skr73.58 Million | -34.33% |
| 2020 | Skr112.04 Million | +120.98% |
| 2019 | Skr50.70 Million | -50.48% |
| 2018 | Skr102.38 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of AlzeCure Pharma was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $95.72 Million USD |
| MoneyControl | $95.72 Million USD |
| MarketWatch | $95.72 Million USD |
| marketcap.company | $95.72 Million USD |
| Reuters | $95.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AlzeCure Pharma
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer's disease, sl… Read more